THE ROLE OF THE SOLUBLE TNF-ALPHA RECEPTORS IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS

• Main Authors: T. M. Bzarova (Author), E. I. Alexeeva (Author), A. N. Fetisova (Author), N. A. Zurikova (Author), S. I. Valieva (Author), R. V. Denisova (Author), E. V. Mitenko (Author), T. V. Sleptsova (Author), K. B. Isaeva (Author), E. G. Chistyakova (Author), N. I. Taibulatov (Author), M. V. Ryazanov (Author), A. V. Anikin (Author), E. I. Zelikovich (Author), G. V. Kurilenkov (Author), E. L. Semikina (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2012-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The results of the study of etanercept (soluble tumor necrosis factor alpha receptors) efficacy and safety in treatment of 97 patients with early and late onset of juvenile idiopathic arthritis are demonstrated in this article. The observation period was 12 months. In 48 weeks of anti-TNF treatment...